cross country healthcare inc. - CCRN

CCRN

Close Chg Chg %
8.94 0.27 3.02%

Open Market

9.21

+0.27 (3.02%)

Volume: 849.75K

Last Updated:

Jan 15, 2026, 3:43 PM EDT

Company Overview: cross country healthcare inc. - CCRN

CCRN Key Data

Open

$8.91

Day Range

8.90 - 9.35

52 Week Range

7.43 - 18.30

Market Cap

$292.87M

Shares Outstanding

32.76M

Public Float

30.58M

Beta

0.45

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.48

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

705.97K

 

CCRN Performance

1 Week
 
8.50%
 
1 Month
 
12.45%
 
3 Months
 
-29.16%
 
1 Year
 
-50.83%
 
5 Years
 
-1.87%
 

CCRN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About cross country healthcare inc. - CCRN

Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the Nurse and Allied Staffing and Physician Staffing segments. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing. The Physician Staffing segment includes certified registered nurse anesthetists, nurse practitioners, and physician assistants. The company was founded by Kevin C. Clark in 1986 and is headquartered in Boca Raton, FL.

CCRN At a Glance

Cross Country Healthcare, Inc.
6551 Park of Commerce Boulevard
Boca Raton, Florida 33487
Phone 1-561-998-2232 Revenue 1.34B
Industry Personnel Services Net Income -14,556,000.00
Sector Commercial Services Employees 1,400
Fiscal Year-end 12 / 2025
View SEC Filings

CCRN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.451
Price to Book Ratio 1.399
Price to Cash Flow Ratio 5.05
Enterprise Value to EBITDA 27.177
Enterprise Value to Sales 0.393
Total Debt to Enterprise Value 0.007

CCRN Efficiency

Revenue/Employee 960,002.857
Income Per Employee -10,397.143
Receivables Turnover 5.534
Total Asset Turnover 2.119

CCRN Liquidity

Current Ratio 2.782
Quick Ratio 2.782
Cash Ratio 0.678

CCRN Profitability

Gross Margin 19.051
Operating Margin 0.092
Pretax Margin -1.22
Net Margin -1.083
Return on Assets -2.295
Return on Equity -3.262
Return on Total Capital -3.443
Return on Invested Capital -3.246

CCRN Capital Structure

Total Debt to Total Equity 0.924
Total Debt to Total Capital 0.915
Total Debt to Total Assets 0.657
Long-Term Debt to Equity 0.425
Long-Term Debt to Total Capital 0.421
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cross Country Healthcare Inc. - CCRN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.68B 2.81B 2.02B 1.34B
Sales Growth
+100.46% +67.39% -28.04% -33.46%
Cost of Goods Sold (COGS) incl D&A
1.31B 2.19B 1.59B 1.09B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
12.28M 14.43M 18.35M 18.20M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+102.91% +67.10% -27.55% -31.47%
Gross Income
365.15M 615.11M 432.06M 256.05M
Gross Income Growth
+92.12% +68.46% -29.76% -40.74%
Gross Profit Margin
+21.78% +21.92% +21.39% +19.05%
2021 2022 2023 2024 5-year trend
SG&A Expense
220.07M 333.82M 314.95M 254.81M
Research & Development
- - - -
-
Other SG&A
220.07M 333.82M 314.95M 254.81M
SGA Growth
+24.45% +51.68% -5.65% -19.10%
Other Operating Expense
- - - -
-
Unusual Expense
5.77M 11.91M 5.02M 18.11M
EBIT after Unusual Expense
139.30M 269.38M 112.09M (16.87M)
Non Operating Income/Expense
770.00K 1.34M (1.10M) 2.65M
Non-Operating Interest Income
- - - 2.05M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
6.87M 14.39M 8.09M 2.19M
Interest Expense Growth
+137.58% +109.60% -43.76% -72.97%
Gross Interest Expense
6.87M 14.39M 8.09M 2.19M
Interest Capitalized
- - - -
-
Pretax Income
133.21M 256.32M 102.89M (16.40M)
Pretax Income Growth
+1,180.36% +92.42% -59.86% -115.94%
Pretax Margin
+7.94% +9.13% +5.09% -1.22%
Income Tax
1.21M 67.86M 30.26M (1.84M)
Income Tax - Current - Domestic
10.80M 62.58M 28.81M (179.00K)
Income Tax - Current - Foreign
330.00K 219.00K 148.00K 281.00K
Income Tax - Deferred - Domestic
(9.76M) 5.01M 1.15M (2.11M)
Income Tax - Deferred - Foreign
(171.00K) 56.00K 154.00K 165.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
132.00M 188.46M 72.63M (14.56M)
Minority Interest Expense
- - - -
-
Net Income
132.00M 188.46M 72.63M (14.56M)
Net Income Growth
+1,118.38% +42.77% -61.46% -120.04%
Net Margin Growth
+7.87% +6.71% +3.60% -1.08%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
132.00M 188.46M 72.63M (14.56M)
Preferred Dividends
- - - -
-
Net Income Available to Common
132.00M 188.46M 72.63M (14.56M)
EPS (Basic)
3.5979 5.0919 2.0659 -0.4361
EPS (Basic) Growth
+1,101.64% +41.52% -59.43% -121.11%
Basic Shares Outstanding
36.69M 37.01M 35.16M 33.38M
EPS (Diluted)
3.5302 5.0208 2.0473 -0.4361
EPS (Diluted) Growth
+1,082.80% +42.22% -59.22% -121.30%
Diluted Shares Outstanding
37.39M 37.54M 35.48M 33.38M
EBITDA
157.35M 295.72M 135.46M 19.44M
EBITDA Growth
+434.56% +87.94% -54.19% -85.65%
EBITDA Margin
+9.38% +10.54% +6.71% +1.45%

Snapshot

Average Recommendation HOLD Average Target Price 11.815
Number of Ratings 8 Current Quarters Estimate 0.01
FY Report Date 03 / 2026 Current Year's Estimate 0.082
Last Quarter’s Earnings 0.02 Median PE on CY Estimate N/A
Year Ago Earnings 0.10 Next Fiscal Year Estimate 0.088
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 8 5
Mean Estimate 0.01 0.01 0.08 0.09
High Estimates 0.03 0.06 0.32 0.20
Low Estimate 0.00 -0.02 -0.04 0.02
Coefficient of Variance 123.68 203.14 141.80 89.81

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 0
OVERWEIGHT 0 0 0
HOLD 7 7 6
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Cross Country Healthcare Inc. - CCRN

Date Name Shares Transaction Value
Mar 24, 2025 Susan E. Ball General Counsel and Secretary 185,418 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 William J. Burns Chief Financial Officer 255,973 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Karen Mote Pres., Cross Country Locums 26,961 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Colin P. McDonald Chief Human Resources Officer 26,848 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 John A. Martins President, CEO; Director 180,762 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Phillip Noe Chief Information Officer 13,750 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 Marc Krug Group President, Delivery 40,502 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 24, 2025 James V. Redd Chief Accounting Officer 20,836 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Cross Country Healthcare Inc. in the News